Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection
2007 ◽
Vol 32
(1)
◽
pp. 57-65
◽
2007 ◽
Vol 32
(1)
◽
pp. 57-65
◽
2019 ◽
Keyword(s):
1987 ◽
Vol 104
(1-2)
◽
pp. 183-190
◽
Keyword(s):
Keyword(s):
1986 ◽
Vol 83
(6)
◽
pp. 1877-1880
◽
Keyword(s):
2005 ◽
Vol 280
(25)
◽
pp. 23820-23828
◽
2007 ◽
Vol 282
(33)
◽
pp. 23799-23810
◽
2019 ◽
Vol 49
(11)
◽
pp. 2083-2094
◽
Keyword(s):
1985 ◽
Vol 96
(1)
◽
pp. 235-240
◽